ArticlePLoS computational biology2013
Quantifying chaperone-mediated transitions in the proteostasis network of E. coli.
Article in PLoS computational biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 6 citations in OpenAlex.
- The Proteome Folding Problem and Cellular Proteostasis.Journal of molecular biology · 2021Review
- Kinetic versus thermodynamic control of mutational effects on protein homeostasis: A perspective from computational modeling and experiment.Protein science : a publication of the Protein Society · 2019Article
- Bacterial proteostasis balances energy and chaperone utilization efficiently.Proceedings of the National Academy of Sciences of the United States of America · 2017Article
- Individual and collective contributions of chaperoning and degradation to protein homeostasis in E. coli.Cell reports · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For cells to function, the concentrations of all proteins in the cell must be maintained at the proper levels (proteostasis). This task--complicated by cellular stresses, protein misfolding, aggregation, and degradation--is performed by a collection of chaperones that alter the configurational landscape of a given client protein through the formation of protein-chaperone complexes. The set of all such complexes and the transitions between them form the proteostasis network. Recently, a computational model was introduced (FoldEco) that synthesizes experimental data into a system-wide description of the proteostasis network of E. coli. This model describes the concentrations over time of all the species in the system, which include different conformations of the client protein, as well as protein-chaperone complexes. We apply to this model a recently developed analysis tool to calculate mediation probabilities in complex networks. This allows us to determine the probability that a given chaperone system is used to mediate transitions between client protein conformations, such as folding, or the correction of misfolded conformations. We determine how these probabilities change both across different proteins, as well as with system parameters, such as the synthesis rate, and in each case reveal in detail which factors control the usage of one chaperone system over another. We find that the different chaperone systems do not operate orthogonally and can compensate for each other when one system is disabled or overworked, and that this can complicate the analysis of "knockout" experiments, where the concentration of native protein is compared both with and without the presence of a given chaperone system. This study also gives a general recipe for conducting a transition-path-based analysis on a network of coupled chemical reactions, which can be useful in other types of networks as well.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.